[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361767-105":59,"doc-detail-361767-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","is-the-vil-10-protein-from-cytomegalovirus-associated-with-the-potential-development-of-acute-lymphoblastic-leukemia-academic-paper","Is the vIL-10 Protein from Cytomegalovirus Associated with the Potential Development of Acute Lymphoblastic Leukemia? - Academic Paper","","Leukemia is a hematologic malignancy, with acute lymphoblastic leukemia (ALL) being especially prevalent in children. Members of the Orthoherpesviridae family generate proteins during latent infection that may contribute to cancer development. This paper focuses on viral interleukin-10 (vIL-10), which structurally resembles human IL-10, and examines how limited characterization of cytomegalovirus latent-phase proteins constrains understanding. It investigates whether hCMV-driven inflammation and hallmarks of carcinogenesis relate to leukemia progression, aiming to assess vIL-10’s role during hCMV latency as a potential leukemia-development factor.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/is-the-vil-10-protein-from-cytomegalovirus-associated-with-the-potential-development-of-acute-lymphoblastic-leukemia-academic-paper/361767/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/is-the-vil-10-protein-from-cytomegalovirus-associated-with-the-potential-development-of-acute-lymphoblastic-leukemia-academic-paper/361767.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study investigate about vIL-10 and leukemia?","Question",{"text":112,"@type":113},"The study investigates whether the viral interleukin-10 (vIL-10) protein from cytomegalovirus is associated with the potential development of acute lymphoblastic leukemia.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why is acute lymphoblastic leukemia (ALL) emphasized in the document?",{"text":117,"@type":113},"ALL is described as the most prevalent leukemia subtype among children, making it a key focus for understanding disease mechanisms and progression.",{"name":119,"@type":110,"acceptedAnswer":120},"How do latent-phase viral proteins and inflammation relate to cancer development in this context?",{"text":121,"@type":113},"Latent-phase proteins from cytomegalovirus may contribute to cancer development, and infection-related inflammatory responses—through cytokine and chemokine release—may help explain how hCMV influences oncogenesis in pediatric ALL.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},361767,1790217695,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Review  \nIs the vIL-10 Protein from Cytomegalovirus Associated with the Potential Development of Acute Lymphoblastic Leukemia?  \nRuvalcaba-Hernández Pamela 1,2, Mata-Rocha Minerva 3, Cruz-Muñoz Mario Ernesto 4, Mejía-Aranguré Juan Manuel 5,6, Sánchez-Escobar Norberto 3,7, Arenas-Huertero Francisco 8, Melchor-Doncel de la Torre Silvia 1, Rangel-López Angélica 1, Jiménez-Hernández Elva 9,  \nNuñez-Enriquez Juan Carlos 10, Ochoa Sara 11, Xicohtencatl-Cortes Juan 11, Cruz-Córdova Ariadnna 12, Figueroa-Arredondo Paula 13,* and Arellano-Galindo José 1,14, *  \nAcademic Editor: Michael McVoy  \nReceived: 29 December 2024  \nRevised: 1 March 2025  \nAccepted: 14 March 2025  \nPublished: 18 March 2025  \nCitation: Pamela, R.-H.; Minerva, M.-R.; Ernesto, C.-M.M.; Manuel, M.-A.J.; Norberto, S.-E.; Francisco, A.-H.; de la Torre Silvia, M.-D.; Angélica, R.-L.; Elva, J.-H.; Carlos, N.-E.J.; et al. Is the vIL-10 Protein from Cytomegalovirus Associated with the Potential Development of Acute Lymphoblastic Leukemia? Viruses 2025, 17, 435. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/v17030435](10.3390/v17030435)  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Laboratorio de Virología, Unidad de Investigación en Enfermedades Infecciosas, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico; [pame.maeunam@gmail.com](pame.maeunam@gmail.com) (R.-H.P.);  \n[melchor.sp@gmail.com](melchor.sp@gmail.com) (M.-D.d.l.T.S.); [angelica.rangel@imss.gob.mx](angelica.rangel@imss.gob.mx) (R.-L.A.)  \n2 Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico  \n3 Unidad de Investigación en Genética Humana, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Avenida Cuauhtémoc 330, Doctores, Ciudad de México 06720, Mexico; [mmata@conacyt.mx](mmata@conacyt.mx) (M.-R.M.); [venancio.saes@gmail.com](venancio.saes@gmail.com) (S.-E.N.)  \n4 Facultad de Medicina, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, Mexico; [mario.cruz@uaem.mx](mario.cruz@uaem.mx)  \n5 Laboratorio de Genómica Funcional del Cáncer, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City 14610, Mexico; [jmejia@inmegen.gob.mx](jmejia@inmegen.gob.mx)  \n6 Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico  \n7 Facultad de Medicina y Cirugía, Universidad Autónoma “Benito Juárez” de Oaxaca, Oaxaca City 68120, Mexico  \n8 Laboratorio de Investigación en Patología Experimental, Hospital Infantil de México Federico Gómez, Ciudad de México 06720, Mexico; [farenashuertero@yahoo.com.mx](farenashuertero@yahoo.com.mx)  \n9 Departamento de Oncología, Hospital Pediátrico Moctezuma SEDESA, Universidad Autónoma Metropolitana, Mexico City 09769, Mexico; [elvajimenez@yahoo.com](elvajimenez@yahoo.com)  \n10 Unidad de Investigación Médica en Epidemiología Clínica, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico; [jcarlos_nu@hotmail.com](jcarlos_nu@hotmail.com)  \n11 Laboratorio de Bacteriología Intestinal, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico; [saraariadnah@hotmail.com](saraariadnah@hotmail.com) (O.S.); [juanxico@yahoo.com](juanxico@yahoo.com) (X.-C.J.)  \n12 Laboratorio de Inmunoquímica, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico; [ariadnnacruz@yahoo.com.mx](ariadnnacruz@yahoo.com.mx)  \n13 Escuela Superior de Medicina del Instituto Politécnico Nacional, Mexico City 11340, Mexico  \n14 Centro Interdisciplinario de Ciencias de la Salud Unidad Milpa Alta Instituto Politécnico Nacional, Mexico City 12000, Mexico  \n* [Correspondence: pfi","cbCaisqF8PznJ1Tv","https://ap.wps.com/l/cbCaisqF8PznJ1Tv","pdf",2371461,22,"English","# Abstract\n# Introduction\n## Background on leukemia and ALL\n## Rationale for studying vIL-10 during hCMV latency\n# Keywords","[{\"question\":\"What question does the study investigate about vIL-10 and leukemia?\",\"answer\":\"The study investigates whether the viral interleukin-10 (vIL-10) protein from cytomegalovirus is associated with the potential development of acute lymphoblastic leukemia.\"},{\"question\":\"Why is acute lymphoblastic leukemia (ALL) emphasized in the document?\",\"answer\":\"ALL is described as the most prevalent leukemia subtype among children, making it a key focus for understanding disease mechanisms and progression.\"},{\"question\":\"How do latent-phase viral proteins and inflammation relate to cancer development in this context?\",\"answer\":\"Latent-phase proteins from cytomegalovirus may contribute to cancer development, and infection-related inflammatory responses—through cytokine and chemokine release—may help explain how hCMV influences oncogenesis in pediatric ALL.\"}]","Is the vIL-10 Protein from Cytomegalovirus Associated with the Potential Development of Acute Lymphoblastic Leukemia? - Academic Paper | PDF",1790145546,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aa8a4a1e271019c53acc3f61ee900311.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7d5b9bce5b6981e105c99c5207d896e.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5f4d743ab4d9d713184539c94a5fa8cf.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b5cda8fa120214294ea772e529287bb4.webp",980,1385]